Start free

PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Independence Blue CrossMedicare Advantage · Billing Codes · Medical Policy · Allergy & Immunology, Dermatology, Hematology +6 moreLow impact

MA08.009z, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)

Effective date
Jul 1, 2026
Identified
Oct 29, 2026

Summary

Independence Blue Cross Medicare Advantage reissued policy MA08.009z on 10/28/2026 with no substantive changes to coverage criteria. One HCPCS code narrative was updated: J1569 now includes 'gammagard liquid erc' in addition to 'gammagard liquid'. The policy became effective 07/01/2026 and remains current; verify your billing system reflects the updated J1569 description.

Get alerts when payers change rules like this one

We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

Action · 3 steps
01Already effective 07/01/2026: Verify that your billing system and prior authorization workflows reflect the updated J1569 code description, which now includes 'gammagard liquid erc' alongside 'gammagard liquid'.
02No new coverage restrictions or requirements have been introduced.
03Confirm current applicability by cross-referencing your claims processing system with the updated narrative to ensure accurate coding and reimbursement for SCIG claims under Independence Blue Cross Medicare Advantage plans.

Codes mentioned

J1555J1558J1559J1561J1569J1575

Original notice

MA08.009z, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)
medpolicy.ibx.com · Always check the source before changing claims.
View original ↗

Related changes

See all Independence Blue Cross changes →
08.00.13ao, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)LowEffective Jul 1, 2026 · Medical PolicyMA08.009w, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)MediumEffective Jan 1, 2025 · Medical PolicyMA08.009y, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)MediumEffective Apr 1, 2026 · Medical Policy08.00.13al, Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)MediumEffective Oct 1, 2025 · Medical PolicyBrowse every Independence Blue Cross change in the policy list

Related policy hubs

Independence Blue Cross policiesAllergy & ImmunologyDermatologyHematologyInfectious DiseaseNeurologyOncologyPediatricsRheumatologyTransplant SurgeryCode J1555Code J1558Code J1559Code J1561Code J1569Code J1575

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Policy MonitoringPayer policy, prior auth and coding changes, filtered to your saved searchesOIG ScreeningStaff and vendors screened every month against OIG LEIE, SAM.gov and state Medicaid listsPrior Auth LookupKnow if a service needs prior authorization before you schedule itCredentialing TrackerLicenses, CAQH, Medicare revalidation and payer enrollments, with reminders before anything lapsesCompliance CenterKeep your HIPAA program documented and ready to show
Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account